CoaguSense

CoaguSense, Inc. is headquartered in Fremont, California, and was founded in 2008 with the goal of providing clinicians and patients with more accurate and robust anticoagulation monitoring technology. The company’s lead product is the Coag-Sense® PT/INR Monitoring System, which utilizes a novel direct micromechanical clot detection technology. This proprietary technology mimics the World Health Organization (WHO) gold standard tilt tube method and requires only a minimal blood sample.